A Reversal for EASTON PHARMACEUTICA (OTCMKTS:EAPH) Is Not Near. The Stock Has Rise in Shorts – Weekly Register

October 19, 2017 – By Richard Conner

The stock of EASTON PHARMACEUTICA (OTCMKTS:EAPH) registered an increase of 1240% in short interest. EAPH’s total short interest was 13,400 shares in October as published by FINRA. Its up 1240% from 1,000 shares, reported previously.

About 415,901 shares traded. Easton Pharmaceuticals Inc (OTCMKTS:EAPH) has 0.00% since October 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Easton Pharmaceuticals, Inc. is a development-stage firm engaged in various pharmaceutical sectors and others industries. The company has market cap of $20.52 million. The Firm has a transdermal delivery technology , which is incorporated in a line of therapeutic over-the-counter (OTC) products. It currently has negative earnings. The Firm owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions.

More recent Easton Pharmaceuticals Inc (OTCMKTS:EAPH) news were published by: Seekingalpha.com which released: “Reevaluating The Schwag: Easton Pharmaceuticals, Still Schwag” on July 08, 2014. Also Finance.Yahoo.com published the news titled: “Easton Pharmaceuticals Signs Letter Of Intent to Acquire

Read More Here...

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Trackbacks are closed, but you can post a comment.